p27 Loss Is Associated with Poor Prognosis in Gastroenteropancreatic Neuroendocrine Tumors

Proposal for a Standardized Pathology Report of Gastroenteropancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters

(2013) et al.   Korean Journal of Pathology

MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases

(2010) Vincenzo Corbo et al.   ENDOCRINE-RELATED CANCER

p27kip1: A New Multiple Endocrine Neoplasia Gene?

(2010) Ilaria Marinoni et al.   NEUROENDOCRINOLOGY

Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer

(2009) Timothy J. Duncan et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors

(2008) P. Grabowski et al.   CLINICAL CANCER RESEARCH

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene

(2007) Manuel C. Lemos et al.   HUMAN MUTATION